Isolated central nervous system progression on Crizotinib: An Achilles heel of non-small cell lung cancer with EML4-ALK translocation?

Por Chun, Stephen G., Choe, Kevin S., Iyengar, Puneeth, Yordy, John S., Timmerman, Robert D.
Publicado em 2012

Commissioning and initial stereotactic ablative radiotherapy experience with Vero

Por Solberg, Timothy D., Medin, Paul M., Ramirez, Ezequiel, Ding, Chuxiong, Foster, Ryan D., Yordy, John
Publicado no J Appl Clin Med Phys (2014)

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers

Por Chun, Stephen G, Park, Hyunsil, Pandita, Raj K, Horikoshi, Nobuo, Pandita, Tej K, Schwartz, David L, Yordy, John S
Publicado no Am J Cancer Res (2015)

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer()

Por Vo, Dat T., Karanam, Narasimha Kumar, Ding, Lianghao, Saha, Debabrata, Yordy, John S., Giri, Uma, Heymach, John V., Story, Michael D.
Publicado no Neoplasia (2019)

Role of 53BP1 in the Regulation of DNA Double-Strand Break Repair Pathway Choice

Por Gupta, Arun, Hunt, Clayton R., Chakraborty, Sharmistha, Pandita, Raj K., Yordy, John, Ramnarain, Deepti B., Horikoshi, Nobuo, Pandita, Tej K.
Publicado em 2013

Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms

Por Findlay, Victoria J., Turner, David P., Yordy, John S., McCarragher, Brent, Shriver, Marey R., Szalai, Gabor, Watson, Patricia M., LaRue, Amanda C., Moussa, Omar, Watson, Dennis K.
Publicado em 2011

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence

Por Skinner, Heath D., Sandulache, Vlad C., Ow, Thomas J., Meyn, Raymond E., Yordy, John S., Beadle, Beth M., Fitzgerald, Alison L., Giri, Uma, Ang, K. Kian, Myers, Jeffrey N.
Publicado em 2011

NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer

Por Li, Long-Shan, Reddy, Srilakshmi, Lin, Zhen-Hua, Liu, Shuangping, Park, Hyunsil, Chun, Stephen G., Bornmann, William G., Thibodeaux, Joel, Yan, Jingsheng, Chakrabarti, Gaurab, Xie, Xian-Jin, Sumer, Baran D., Boothman, David A., Yordy, John S.
Publicado no Mol Cancer Ther (2016)

Blasted Cell Line Names

Por Wang, Jing, Byers, Lauren A., Yordy, John S., Liu, Wenbin, Shen, Li, Baggerly, Keith A., Giri, Uma, Myers, Jeffrey N., Ang, K. Kian, Story, Michael D., Girard, Luc, Minna, John D., Heymach, John V., Coombes, Kevin R.
Publicado em 2010

Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4)...

Por Crane, Christopher H., Varadhachary, Gauri R., Yordy, John S., Staerkel, Gregg A., Javle, Milind M., Safran, Howard, Haque, Waqar, Hobbs, Bridgett D., Krishnan, Sunil, Fleming, Jason B., Das, Prajnan, Lee, Jeffrey E., Abbruzzese, James L., Wolff, Robert A.
Publicado em 2011

DNA Repair Biomarker Profiling of Head & Neck Cancer: Ku80 Expression Predicts Locoregional Failure and Death Following Radiotherapy

Por Moeller, Benjamin J., Yordy, John S., Williams, Michelle D., Giri, Uma, Raju, Uma, Molkentine, David P., Byers, Lauren A., Heymach, John V., Story, Michael D., Lee, J. Jack, Sturgis, Erich M., Weber, Randal S., Garden, Adam S., Ang, K. Kian, Schwartz, David L.
Publicado em 2011

Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers

Por Cao, Lifen, Li, Long Shan, Spruell, Christopher, Xiao, Ling, Chakrabarti, Gaurab, Bey, Erik A., Reinicke, Kathryn E., Srougi, Melissa C., Moore, Zachary, Dong, Ying, Vo, Peggy, Kabbani, Wareef, Yang, Chin-Rang, Wang, Xiaoyu, Fattah, Farjana, Morales, Julio C., Motea, Edward A., Bornmann, William G., Yordy, John S., Boothman, David A.
Publicado em 2014

Evolutionary Action score of TP53 (EAp53) identifies high risk mutations associated with decreased survival and increased distant metastases in head and neck cancer

Por Neskey, David M., Osman, Abdullah A., Ow, Thomas J., Katsonis, Panagiotis, McDonald, Thomas, Hicks, Stephanie C., Hsu, Teng-Kuei, Pickering, Curtis R., Ward, Alexandra, Patel, Ameeta, Yordy, John S., Skinner, Heath D., Giri, Uma, Sano, Daisuke, Story, Michael D., Beadle, Beth M., El-Naggar, Adel K., Kies, Merrill S., William, William N., Caulin, Carlos, Frederick, Mitchell, Kimmel, Marek, Myers, Jeffrey N., Lichtarge, Olivier
Publicado no Cancer Res (2015)

Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Por Byers, Lauren Averett, Wang, Jing, Nilsson, Monique B., Fujimoto, Junya, Saintigny, Pierre, Yordy, John, Giri, Uma, Peyton, Michael, Fan, You Hong, Diao, Lixia, Masrorpour, Fatemeh, Shen, Li, Liu, Wenbin, Duchemann, Boris, Tumula, Praveen, Bhardwaj, Vikas, Welsh, James, Weber, Stephanie, Glisson, Bonnie S., Kalhor, Neda, Wistuba, Ignacio I., Girard, Luc, Lippman, Scott M., Mills, Gordon B., Coombes, Kevin R., Weinstein, John N., Minna, John D., Heymach, John V.
Publicado em 2012